Yoonjee Park
Overview
Explore the profile of Yoonjee Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kang D, Kim C, Park Y, Jang W, Kim W, Choi J, et al.
Stroke
. 2020 Jun;
51(7):2188-2196.
PMID: 32513093
Background And Purpose: Cardiopulmonary coupling (CPC) analysis is an easily assessable method to evaluate sleep-disordered breathing (SDB); however, its prognostic impact in patients with acute ischemic stroke needs to be...
12.
Kim Y, Her A, Rha S, Choi B, Choi S, Byun J, et al.
Glob Heart
. 2020 Jun;
15(1):4.
PMID: 32489777
Background: Endeavor®-zotarolimus-eluting stent (E-ZES) was the first ZES to be developed, and Resolute integrity®-ZES (I-ZES) has been developed more recently. Comparative studies on long-term usage of these two ZESs have...
13.
Kim Y, Her A, Rha S, Choi B, Choi S, Byun J, et al.
Anatol J Cardiol
. 2020 May;
23(5):268-276.
PMID: 32352415
Objective: There is a scarcity of comparative studies between Endeavor Resolute®-zotarolimus-eluting stent (R-ZES) and Resolute Integrity®-ZES (I-ZES) during long-term follow-up periods. Although the stent alloy and the polymer of these...
14.
Kim W, Kim J, Rha S, Choi B, Jang W, Kang D, et al.
Heart Vessels
. 2020 Apr;
35(9):1181-1192.
PMID: 32270356
Although potent P2Y12 inhibitor-based dual antiplatelet therapy (DAPT) has replaced clopidogrel-based therapy as the standard treatment in patients with acute myocardial infarction (AMI), there is a concern about the risk...
15.
Kim W, Park S, Kim W, Jang W, Park E, Kang D, et al.
J Cardiopulm Rehabil Prev
. 2020 Mar;
40(2):E10-E13.
PMID: 32118655
Purpose: A recent study has shown that quadriceps strength can be used to predict the level of exercise capacity in patients with coronary heart disease. We investigated whether the relationship...
16.
Jang W, Kim W, Kang D, Park Y, Lee J, Choi J, et al.
J Clin Med
. 2019 Dec;
8(12).
PMID: 31842294
We investigated reference values for cardiorespiratory fitness (CRF) for healthy Koreans and Koreans with coronary heart disease (CHD) and used them to identify inter-ethnic differences in CRF, differences over time...
17.
Kim Y, Her A, Rha S, Choi B, Choi S, Byun J, et al.
J Geriatr Cardiol
. 2019 Sep;
16(8):639-647.
PMID: 31555332
Background: There are limited data comparing long-term clinical outcomes between first-generation (1G) and second-generation (2G) drug-eluting stents (DESs) in patients who underwent successful percutaneous coronary intervention (PCI) for coronary chronic...
18.
Kim Y, Her A, Rha S, Choi B, Choi S, Byun J, et al.
Medicine (Baltimore)
. 2019 Aug;
98(32):e16767.
PMID: 31393396
There are limited long-term outcome data comparing BioLinx polymer (B)-zotarolimus-eluting stents (ZES) with phosphorylcholine polymer (P)-ZES. The aim of this study was to compare the efficacy and safety of B-ZES...
19.
Kim Y, Her A, Rha S, Choi B, Choi S, Byun J, et al.
J Geriatr Cardiol
. 2019 Jul;
16(6):439-447.
PMID: 31308836
Background: In real practice, two or more antihypertensive drugs are needed to achieve target blood pressure. We investigated the comparative beneficial actions of combination therapy of renin-angiotensin system inhibitors (RASI),...
20.
Lee M, Choi B, Hollowed J, Han S, Baek M, Ryu Y, et al.
Cardiovasc Revasc Med
. 2019 May;
21(1):110-115.
PMID: 31072790
Percutaneous transluminal angioplasty (PTA) is an effective treatment strategy for peripheral artery disease (PAD). Data are limiting regarding sex differences in patients with PAD who underwent PTA. We assessed the...